108984 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on peptide bonds (3.4); Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals Cysteine endopeptidases (3.4.22)
COMPOSITIONS, SYSTEMS, AND METHODS FOR REDUCING ADIPOSE TISSUE
#2IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS
#3SUSTAINED TRANSGENE EXPRESSION OF MODIFIED ERT2 PEPTIDE-SUICIDE PROTEIN FUSION POLYPEPTIDES
#4Model for simulating ALS constructed based on CASP4 and its construction method
#5RECOMBINANT ADENO-ASSOCIATED VIRUS PRODUCTS AND METHODS FOR TREATING LIMB GIRDLE MUSCULAR DYSTROPHY 2A
#6ANTI-PSMA SINGLE-CHAIN ANTIBODY, CHIMERIC ANTIGEN RECEPTOR ASSOCIATED THEREWITH AND USE THEREOF
#7COMPOSITIONS FOR EXPOSING FILM-FORMING MICROBES AND METHODS FOR USE OF THE COMPOSITIONS
#8COMPOSITIONS AND METHODS FOR USING ENGINEERED DEUBIQUITINASES FOR PROBING UBIQUITIN-DEPENDENT CELLULAR PROCESSES
#9METHODS AND COMPOSITIONS FOR SELECTIVELY ELIMINATING CELLS OF INTEREST
#10Safety Kill Switches for Engineered Cells Carrying Synthetic Chromosomes
#11MUTANTS OF IMMUNOGLOBULIN-DEGRADING ENZYME IDEE
#12MODULATORS OF MESOTHELIAL ECM MOVEMENT
#13MULTI-SWITCH RECEPTOR ARRAYS AND METHODS FOR IMPROVING IMMUNE CELL FUNCTION
#14PHAGOCYTOSIS ASSAY COMBINING A SYNTHETIC CELL DEATH SWITCH AND A PHAGOCYTOSIS REPORTER SYSTEM
#15COMPOSITIONS AND METHODS FOR USING ENGINEERED DEUBIQUITINASES FOR PROBING UBIQUITIN-DEPENDENT CELLULAR PROCESSES
#16COMPOSITIONS AND METHODS FOR USING ENGINEERED DEUBIQUITINASES FOR PROBING UBIQUITIN-DEPENDENT CELLULAR PROCESSES
#17CAS VARIANTS FOR GENE EDITING
#18SAFETY SWITCHES TO CONTROL IN VITRO AND IN VIVO PROLIFERATION OF CELL THERAPY PRODUCTS
#19IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS
#20GD2 CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
#21METHODS OF SORTING CELLS FOR PHOTORECEPTOR TRANSPLANTATION TREATMENT
#22METHODS AND COMPOSITIONS FOR DETERMINING THE ANTIGEN SPECIFICITY OF T CELLS
#23IMMUNE CELL COMPOSITIONS AND METHODS OF USE
#24MODIFIED CASPASE-9 POLYPEPTIDES AND METHODS OF USE THEREOF
#25TREATMENT OF ADVANCED IgA NEPHROPATHY
#26COMPOSITIONS AND METHODS FOR USING ENGINEERED DEUBIQUITINASES FOR PROBING UBIQUITIN-DEPENDENT CELLULAR PROCESSES
#27COMPOSITIONS AND METHODS FOR USING ENGINEERED DEUBIQUITINASES FOR PROBING UBIQUITIN-DEPENDENT CELLULAR PROCESSES
#28Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes
#29TEV Protease with Dual Affinity Tags
#30DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#31MESENCHYMAL STEM CELL LINE
#32INDUCIBLE TISSUE CONSTRUCTS AND USES THEREOF
#33METHOD FOR CONSTITUTIVE MALT1 PROTEASE ACTIVATION
#34PREPARATION METHOD FOR POLYPEPTIDE
#35CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS
#36CYTOPLASMIC INCOMPATIBILITY FACTORS AND METHODS FOR CONTROLLING ANTHROPODS
#37IMMUNOGENIC PROTEIN HYDROLYSATE WITH REDUCED ALLERGENICITY
#38Crystal Structure of The Human G267s Calpain-5 Protease Core Domain and Its Use in Rational Drug Design for Identifying Inhibitors of Calpain-5
#39INTRACELLULAR DELIVERY OF THERAPEUTIC PROTEINS DESIGNED TO INVADE AND AUTONOMOUSLY LYSE AND METHODS OF USE THEREOF
#40Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes
#41Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes
#42Compositions and methods for preparing capped mRNA
#43ANTI-IDIOTYPE COMPOSITIONS AND METHODS OF USE THEREOF
#44CYSTEINE PROTEASE
#45CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#46A NOVEL MUSCLE-SPECIFIC PROMOTER
#47COMPOSITIONS FOR EXPOSING FILM-FORMING MICROBES AND METHODS FOR USE OF THE COMPOSITIONS
#48CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME
#49METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#50ORTHOGONAL SAFETY SWITCHES TO ELIMINATE GENETICALLY ENGINEERED CELLS
#51DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#52IMMUNORESPONSIVE CELLS ARMOURED WITH SPATIOTEMPORALLY RESTRICTED ACTIVITY OF CYTOKINES OF THE IL-1 SUPERFAMILY
#53ENGINEERED CELLS AND USES THEREOF
#54METHODS AND COMPOSITIONS FOR THE POSITIVE SELECTION OF PROTEIN DESTABILIZERS
#55AAV CARDIAC GENE THERAPY FOR CARDIOMYOPATHY IN HUMANS
#56IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS
#57Modified caspase-9 polypeptides and methods of use thereof
#58METHODS FOR PREPARATION OF ACTIVE SEPARASE
#59METHOD FOR EXPRESSING AND PURIFYING PROTEIN BY USING CSQ-TAG
#60DNA, EXPRESSION VECTOR, TRANSCRIPT, CELL, PHARMACEUTICAL COMPOSITION, AND MEDICINE
#61Method of screening inhibitor of caspase activity by lipopolysaccharide
#62CELLS FOR IMPROVED IMMUNOTHERAPY AND USES THEREOF
#63Composition and Methods for Evading Humoral Immunity
#64METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
#65GENE EXPRESSION CASSETTE FOR EXPRESSING N-TERMINAL METHIONINE-TRUNCATED PROTEIN OF INTEREST AND METHOD FOR PRODUCING N-TERMINAL METHIONINE-TRUNCATED PROTEIN OF INTEREST BY USING SAME
#66Cas variants for gene editing
#67Immune cell compositions and methods of use
#68FUSOGENIC LIPID NANOPARTICLES FOR THE TARGET CELL-SPECIFIC PRODUCTION OF RAPAMYCIN INDUCIBLE THERAPEUTIC PROTEINS
#69CR3022 chimeric antigen receptors and methods of use
#70T CELLS WITH SUICIDE SWITCH
#71ROBO1 CAR-NK CELL CARRYING SUICIDE GENE, PREPARATION METHOD AND APPLICATION THEREOF
#72COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
#73GD2-based chimeric antigen receptor and application thereof
#74RECOMBINANT ADENO-ASSOCIATED VIRUS PRODUCTS AND METHODS FOR TREATING LIMB GIRDLE MUSCULAR DYSTROPHY 2A
#75FLT3 DIRECTED CAR CELLS FOR IMMUNOTHERAPY
#76LYSINE REACTIVE PROBES AND USES THEREOF
#77METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#78INDUCIBLE TISSUE CONSTRUCTS AND USES THEREOF
#79Application of Substances Containing AuCs in Preparing Medicine for Preventing and Treating Alzheimer's Disease
#80Substances Containing AuCs and Preparation Method and Use Thereof
#81METHODS AND COMPOSITIONS FOR THE TREATMENT OF OSTEOPETROSIS
#82Methods to create chemically-induced dimerizing protein systems for regulation of cellular events
#83LEUCINE ZIPPER-BASED COMPOSITIONS AND METHODS OF USE
#84RECOMBINANT FUSION PROTEIN AND IMMUNOGENIC COMPOSITION
#85ENGINEERED CELL DEATH-INDUCING ENZYMES AND METHODS OF USE
#86Bacterial strain clostridium histolyticum and methods of use thereof
#87CYSTEINE REACTIVE PROBES AND USES THEREOF
#88Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes
#89Costimulation of chimeric antigen receptors by MYD88 and CD40 polypeptides
#90Methods for inducing partial apoptosis using caspase polypeptides
#91Chimeric protein
#92THIOL-BASED DEEP EUTECTIC SOLVENT
#93Cysteine protease
#94PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#95Immune cells expressing engineered antigen receptors
#96Substances containing AuCs and preparation method and use thereof
#97Light-gated signaling modulation
#98Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide
#99Process for determining enzyme activity in a cell by activity-based reporter gene technology (ABRGT)
#100Cas variants for gene editing
#101Substances containing AuCs and preparation method and use thereof
#102SCALABLE HIGH RECOVERY METHODS FOR PRODUCING HIGH YIELD RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTOR AND RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTORS PRODUCED THEREBY
#103Methods and composition for detecting CAPN5
#104Methods and compositions for the positive selection of protein destabilizers
#105T CELL RECEPTORS DIRECTED AGAINST BOB1 AND USES THEREOF
#106Cytoplasmic incompatibility factors and methods for controlling anthropods
#107METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#108Chimeric antigen receptors and uses thereof
#109Modified caspase-9 polypeptides and methods of use thereof
#110Nano/micromotors for active and dynamic intracellular payload delivery
#111Functionalized nanoparticles for enhanced affinity precipitation of proteins
#112Methods of screening and treatment with USP4 inhibitors
#113Application of substances containing AuCs in preparing medicine for preventing and treating Alzheimer's disease
#114Chimeric protein
#115Compositions for the treatment of gluten intolerance and uses thereof
#116LYSINE REACTIVE PROBES AND USES THEREOF
#117Methods to create chemically-induced dimerizing protein systems for regulation of cellular events
#118Immune cell compositions and methods of use
#119Selective gene therapy expression system
#120MODIFIED CASPASE POLYPEPTIDES AND USES THEREOF
#121Methods for inducing partial apoptosis using caspase polypeptides
#122Treating type I and type II diabetes
#123FLT3 directed car cells for immunotherapy
#124Use of cysteine endoprotease for reducing cloudiness in drinks
#125Cysteine proteases
#126Recombinant Phe-free proteins for use in the treatment of phenylketonuria
#127Chimeric protein
#128Methods for enzyme mediated polypeptide conjugation
#129THIOL-BASED DEEP EUTECTIC SOLVENT
#130DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#131METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#132Cysteine reactive probes and uses thereof
#133Near-infrared light-activated proteins
#134Modified Caspase polypeptides and uses thereof
#135Means and methods for detecting activated MALT1
#136Cas variants for gene editing
#137Cell-penetrating peptides
#138A METHOD FOR ANALYSING A SAMPLE IMMUNOGLOBULIN MOLECULES
#139METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
#140Methods for inducing partial apoptosis using caspase polypeptides
#141T cell receptors directed against Bob1 and uses thereof
#142Selective gene therapy expression system
#143Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides
#144Cathepsin L inhibitors and probes comprising vinyl sulfonate moiety and methods of using same
#145CASPASE POLYPEPTIDES HAVING MODIFIED ACTIVITY AND USES THEREOF
#146Method for the determination of botulinum neurotoxin biological activity
#147Method and apparatus for analyzing biomolecules using Raman spectroscopy
#148DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES
#149Methods for nucleic acid editing
#150Fusions of Cas9 domains and nucleic acid-editing domains
#151Fluorescent separase activity sensor
#152Cell-penetrating peptides
#153Methods of Screening for Inhibitors of Enzymes
#154GINGIPAIN INHIBITORY PROPEPTIDES
#155Methods of treatment of cellulite
#156Modified caspase polypeptides and uses thereof
#157Evolution of bond-forming enzymes
#158Method for the determination of botulinum neurotoxin biological activity
#159Signal peptide for producing a polypeptide
#160Protective structure of substance to be protected, method of protecting substance to be protected, enzymatic reaction method, method of producing reaction product, method for adjusting the speed of enzymatic reaction, and enzyme material use kit
#161USP2a peptides and antibodies
#162PRODUCTION OF RECOMBINANT SELENOPROTEIN MUTANTS WITH ENHANCED CATALYTIC ACTIVITY
#163Near-infrared light-activated proteins
#164NOVEL CASPASE-2 INHIBITORS
#165Signal peptide for producing a polypeptide
#166Compositions for the treatment of gluten intolerance and uses thereof
#167PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#168Component of bromelain
#169MOLECULES AND METHODS FOR MODULATING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)
#170Production of recombinant selenoprotein mutants with enhanced catalytic activity
#171Expression of the cysteine protease legumain in vascular and inflammatory diseases
#172Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
#173ANTIBODY AND USES THEREOF
#174Methods of treatment of collagen-mediated diseases and conditions
#175Novel human protein kinase, phosphatase, and protease family members and uses thereof
#176Use of Caspase-8 Inhibitors for Modulating Hematopoiesis
#177Novel nucleic acid sequences encoding adenylate kinases, alcohol dehydrogenases, ubiquitin proteases, lipases, adenylate cyclases, and GTPase activators
#178DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES
#179Ubiquitin protease
#180BIOLOGICAL ENTITIES AND THE USE THEREOF
#181BIOLOGICAL ENTITIES AND THE USE THEREOF
#182Caspase-9 deficient animals and the use thereof
#183Signal peptide for producing a polypeptide
#184DNA MARKER FOR MEAT TENDERNESS IN CATTLE
#185Proteolytically cleavable fusion proteins with high molar specific activity
#186Methods for the early diagnosis of ovarian cancer
#187Human Osteoclast Derived Cathepsin
#188Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme
#189Proteolytically cleavable fusion proteins with high molar specific activity
#190Chymopapain Isoenzymes, Compositions, and Uses Thereof
#191Compositions and method for regulating ubiquitin-specific processing proteases
#192Ubiqutin proteases
#193Expression of the cysteine protease legumain in vascular and inflammatory diseases
#194Use of Caspase-8 Inhibitors for Modulating Hematopoiesis
#195Fusion proteins and methods of cleavage of such proteins
#196Method and composition for treating obesity by targeting cathespin
#197Human Protease Molecules
#198Human protein kinase, phosphatase, and protease family members and uses thereof
#199Antibody directed against a ubiquitin-specific protease occurring in the brain
#200Use of protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
#201Method of degrading transcriptional factors of saccharometabolism-associated gene, method for inhibiting the degradation, and agent for inhibiting degradation and degradation inhibitor
#202Nucleic acids encoding Cry8Bb1 endotoxins engineered to have insect-specific protease recognition sequences
#203Cathepsin-associated genetically modified nonhuman mammal
#204Methods of treatment of type 2 diabetes
#205Method and composition for reducing blood sugar levels or fat storage by targeting cathepsin
#206Nitrosated and nitrosylated heme proteins
#207Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality
#208Polynucleotide encoding a novel cysteine protease of the calpain superfamily, CAN-12, and variants thereof
#209Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
#210Transgenic mice containing lumulus clotting factor protease-like gene disruptions
#211Ubiquitin protease
#212Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto
#213Ubiquitin-specific protease occurring in the brain and DNA encoding the same
#214Human cathepsin
#215Human osteoclast derived cathepsin
#216Signal peptide for producing a polypeptide
#217Human protein kinase, phosphatase, and protease family members and uses thereof
#218Human protease molecules
#219Semisynthetic protein-based site-directed probes for identification and inhibition of active sites, and methods therefor
#220Proteases
#221Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof
#222Methods for detecting expression of human protease molecules
#223Methods for the early diagnosis of ovarian cancer
#224Compositions and methods for the treatment and diagnosis of immune disorders
#225Engineered enzymes and uses thereof
#226Human osteoclast derived cathepsin